As reported on NutraceuticalsWorld.com on April 5, 2022

PanTheryx has expanded its capacity to integrate five beneficial strains into combination products with bovine colostrum. The new formulation capability will give manufacturers the option to create combination products with colostrum and strains such as Bifidobacterium animalis BB-12, Lactobacillus rhamnosus LGG+, Lactobacillus plantarum HEAL9, Lactobacillus paracasei 8700:2, and B. subtilis DE111.

“Colostrum is an ideal partner for probiotics since it can promote the growth and colonization of these beneficial microbial strains, creating powerful synbiotic combinations. We are proud to be able to offer this capability to dietary supplement manufacturers, so they can create new digestive and immune health duo products. We look forward to continuing to explore new ways to innovate products for our ColostrumOne bovine (cow) colostrum ingredient offering,” said Mike Weiser, PhD, senior director of innovation and R&D, PanTheryx.

Read the full article here: NutraceuticalsWorld.com